New drug price determination process needs fundamental reform.

Published: 2006-05-16 06:56:00

Updated: 2006-05-16 06:56:00

In a meeting on the subject of "Problems and reform programs for the drug pricing system of Korea" on May 11 sponsored by several civic groups, Mr. Woo Seok-gyun of the Korean Federation of Medical Groups for Health Rights (KFHR) said that the new drug price determination should be fundamentally ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK